Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LINC00514 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
BRF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PCGF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GSK3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CARHSP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAPDH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL13AP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXO42 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RHBDD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEC13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACTB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C17orf80 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
S100A13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CT45A8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on